SMARCB1-Deficient Cancers: Novel Molecular Insights and Therapeutic Vulnerabilities.

SMARCB1-deficient cancer chromatin epigenetics rhabdoid tumor structure therapeutics

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
27 Jul 2022
Historique:
received: 25 06 2022
revised: 20 07 2022
accepted: 20 07 2022
entrez: 27 7 2022
pubmed: 28 7 2022
medline: 28 7 2022
Statut: epublish

Résumé

SMARCB1 is a critical component of the BAF complex that is responsible for global chromatin remodeling. Loss of SMARCB1 has been implicated in the initiation of cancers such as malignant rhabdoid tumor (MRT), atypical teratoid rhabdoid tumor (ATRT), and, more recently, renal medullary carcinoma (RMC). These SMARCB1-deficient tumors have remarkably stable genomes, offering unique insights into the epigenetic mechanisms in cancer biology. Given the lack of druggable targets and the high mortality associated with SMARCB1-deficient tumors, a significant research effort has been directed toward understanding the mechanisms of tumor transformation and proliferation. Accumulating evidence suggests that tumorigenicity arises from aberrant enhancer and promoter regulation followed by dysfunctional transcriptional control. In this review, we outline key mechanisms by which loss of SMARCB1 may lead to tumor formation and cover how these mechanisms have been used for the design of targeted therapy.

Identifiants

pubmed: 35892904
pii: cancers14153645
doi: 10.3390/cancers14153645
pmc: PMC9332782
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : NIGMS NIH HHS
ID : T32GM008490
Pays : United States
Organisme : American Cancer Society
ID : MRSG-18-202-01
Organisme : Ian's Friends Foundation
ID : NA
Organisme : UnRavel Pediatric Cancer
ID : NA
Organisme : United States Department of Defense
ID : W81XWH-18-PRCRP-CDA

Références

Oncologist. 2012;17(10):1317-22
pubmed: 22927469
Cancer Res. 1999 Jan 1;59(1):74-9
pubmed: 9892189
Clin Genet. 2014 Jun;85(6):548-54
pubmed: 23815551
EMBO Mol Med. 2021 Feb 5;13(2):e12640
pubmed: 33332735
Cancer Cell. 2019 Feb 11;35(2):204-220.e9
pubmed: 30753823
Elife. 2018 Nov 15;7:
pubmed: 30431433
Cancer Cell. 2002 Nov;2(5):415-25
pubmed: 12450796
Biomedicines. 2022 Mar 11;10(3):
pubmed: 35327458
Br J Cancer. 2001 Jan;84(2):199-201
pubmed: 11161377
Neuro Oncol. 2020 May 15;22(5):613-624
pubmed: 31889194
Nat Commun. 2018 Dec 3;9(1):5139
pubmed: 30510198
J Clin Invest. 2011 Oct;121(10):3834-45
pubmed: 21926465
Nucleic Acids Res. 2019 Jan 8;47(D1):D941-D947
pubmed: 30371878
J Pathol. 2016 Jan;238(1):63-73
pubmed: 26365879
Cold Spring Harb Perspect Biol. 2016 Sep 01;8(9):
pubmed: 27194046
Cell. 2018 Nov 15;175(5):1272-1288.e20
pubmed: 30343899
Cancers (Basel). 2022 Jul 05;14(13):
pubmed: 35805058
Int J Cancer. 2019 Apr 15;144(8):1983-1995
pubmed: 30230537
Mod Pathol. 2007 Sep;20(9):914-20
pubmed: 17643096
Clin Cancer Res. 2020 Jun 15;26(12):2882-2890
pubmed: 32122923
Nat Cell Biol. 2018 Dec;20(12):1410-1420
pubmed: 30397315
Nature. 2019 Oct;574(7778):432-436
pubmed: 31597964
Lancet Oncol. 2020 Nov;21(11):1423-1432
pubmed: 33035459
Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21931-6
pubmed: 21106759
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Lancet Oncol. 2015 May;16(5):569-82
pubmed: 25882982
J Adv Pract Oncol. 2022 Mar;13(2):158-163
pubmed: 35369397
Neurogenetics. 2010 Feb;11(1):73-80
pubmed: 19582488
Nat Struct Mol Biol. 2006 Apr;13(4):339-46
pubmed: 16518397
Adv Anat Pathol. 2021 Jan;28(1):44-58
pubmed: 32960834
J Biol Chem. 2018 Mar 16;293(11):3892-3903
pubmed: 29374058
Cancer Discov. 2017 Aug;7(8):818-831
pubmed: 28572459
Nat Genet. 1999 May;22(1):102-5
pubmed: 10319872
Commun Biol. 2022 Jun 6;5(1):549
pubmed: 35668117
EMBO J. 1996 Oct 1;15(19):5370-82
pubmed: 8895581
J Med Genet. 2008 Jun;45(6):332-9
pubmed: 18285426
Nature. 2017 Feb 16;542(7641):362-366
pubmed: 28178232
Transcription. 2012 Jan-Feb;3(1):2-7
pubmed: 22456313
Cancer Res. 2019 May 1;79(9):2404-2414
pubmed: 30755442
Nature. 2001 Dec 20-27;414(6866):924-8
pubmed: 11780067
Am J Med Genet C Semin Med Genet. 2014 Sep;166C(3):262-75
pubmed: 25168959
Am J Med Genet C Semin Med Genet. 2014 Sep;166C(3):257-61
pubmed: 25081545
Nat Commun. 2017 Jul 14;8:16080
pubmed: 28706277
Nat Commun. 2017 Mar 06;8:14648
pubmed: 28262751
Cell. 2013 Jan 17;152(1-2):248-61
pubmed: 23332759
Mod Pathol. 2013 Mar;26(3):385-92
pubmed: 23060122
J Virol. 1996 Sep;70(9):6020-8
pubmed: 8709224
Hum Mol Genet. 1995 Jun;4(6):1097-9
pubmed: 7655467
Mol Cell. 2013 Mar 7;49(5):825-37
pubmed: 23473601
Cell. 2019 Nov 27;179(6):1342-1356.e23
pubmed: 31759698
Pediatr Investig. 2022 May 23;6(2):111-122
pubmed: 35774526
Mol Oncol. 2013 Jun;7(3):497-512
pubmed: 23375777
Cancer Res. 2009 Oct 15;69(20):8094-101
pubmed: 19789351
Nat Genet. 2017 Nov;49(11):1613-1623
pubmed: 28945250
Cell Stem Cell. 2019 Jan 3;24(1):138-152.e8
pubmed: 30609396
Oncotarget. 2015 Oct 27;6(33):34680-90
pubmed: 26415226
Nat Commun. 2019 Apr 23;10(1):1881
pubmed: 31015438
Am J Hum Genet. 2018 May 3;102(5):943-955
pubmed: 29706350
Nat Rev Mol Cell Biol. 2017 Jul;18(7):407-422
pubmed: 28512350
Gene. 2022 Aug 5;834:146638
pubmed: 35680019
Lab Invest. 2010 May;90(5):724-38
pubmed: 20212451
Clin Epigenetics. 2021 Jul 8;13(1):138
pubmed: 34238359
Oncogene. 2011 May 5;30(18):2087-97
pubmed: 21297668
Elife. 2019 Apr 29;8:
pubmed: 31033435
Science. 1994 Dec 23;266(5193):2002-6
pubmed: 7801128
Nat Genet. 2017 Feb;49(2):213-222
pubmed: 27941796
Nat Commun. 2019 May 1;10(1):2014
pubmed: 31043611
Am J Surg Pathol. 2017 Jan;41(1):56-61
pubmed: 27635948
Structure. 2015 Jul 7;23(7):1344-9
pubmed: 26073604
Cancer Genet. 2014 Sep;207(9):358-64
pubmed: 25246033
Annu Rev Biochem. 2009;78:273-304
pubmed: 19355820
Cell Rep. 2019 Nov 19;29(8):2338-2354.e7
pubmed: 31708418
Am J Surg Pathol. 2004 May;28(5):644-50
pubmed: 15105654
Nat Commun. 2021 Mar 3;12(1):1407
pubmed: 33658498
Sci Adv. 2015 Jun 12;1(5):e1500447
pubmed: 26601204
J Neurosurg. 1990 Nov;73(5):710-4
pubmed: 2213160
Am J Hum Genet. 2007 Apr;80(4):805-10
pubmed: 17357086
Proc Natl Acad Sci U S A. 2011 Oct 4;108(40):16669-74
pubmed: 21949397
Science. 2020 Feb 21;367(6480):875-881
pubmed: 32001526
Cancer Cell. 2020 May 11;37(5):720-734.e13
pubmed: 32359397
Cell. 2013 Apr 11;153(2):320-34
pubmed: 23582323
Proc Natl Acad Sci U S A. 2013 Jun 18;110(25):10165-70
pubmed: 23723349
FEBS J. 2018 Nov;285(22):4165-4180
pubmed: 30222246
Genes Chromosomes Cancer. 1990 Sep;2(3):210-6
pubmed: 1964081
Neurooncol Adv. 2020 Apr 14;2(1):vdaa051
pubmed: 32642704
Am J Surg Pathol. 2017 Apr;41(4):458-471
pubmed: 28291122
Proc Natl Acad Sci U S A. 2013 May 7;110(19):7922-7
pubmed: 23620515
J Med Genet. 2011 Feb;48(2):93-7
pubmed: 20930055
Nature. 1998 Jul 9;394(6689):203-6
pubmed: 9671307
Elife. 2019 Mar 12;8:
pubmed: 30860482
Cell. 2013 Apr 11;153(2):307-19
pubmed: 23582322
Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4152-7
pubmed: 9539705
Mol Cell Biol. 1990 Nov;10(11):5616-25
pubmed: 2233708
Nat Immunol. 2008 Jul;9(7):785-93
pubmed: 18500344
Nat Commun. 2016 Jan 28;7:10421
pubmed: 26818002
Nature. 1999 Jun 3;399(6735):487-91
pubmed: 10365963
EMBO J. 2002 Jan 15;21(1-2):31-42
pubmed: 11782423
Int J Mol Sci. 2017 Jul 16;18(7):
pubmed: 28714904
Trends Biochem Sci. 2017 Dec;42(12):977-989
pubmed: 29122461
Cancer Cell. 2019 Jan 14;35(1):95-110.e8
pubmed: 30595504
Clin Cancer Res. 2021 May 15;27(10):2879-2889
pubmed: 33737307
Oncogene. 2002 Aug 8;21(34):5193-203
pubmed: 12149641
Hum Mol Genet. 2012 Dec 15;21(24):5239-45
pubmed: 22949514
Genes Dev. 2013 Dec 15;27(24):2648-62
pubmed: 24285714
Cancer Res. 2021 Feb 15;81(4):820-833
pubmed: 33355184
Mol Cell Biol. 2008 May;28(10):3457-64
pubmed: 18332116
Front Oncol. 2015 Aug 17;5:186
pubmed: 26347853
Nucleic Acids Res. 2017 Jan 4;45(D1):D777-D783
pubmed: 27899578
Cell Rep. 2016 Oct 25;17(5):1265-1275
pubmed: 27783942
J Neuropathol Exp Neurol. 2011 Jul;70(7):596-609
pubmed: 21666498
Acta Neuropathol. 2021 Feb;141(2):291-301
pubmed: 33331994
Cell. 2013 Mar 28;153(1):71-85
pubmed: 23540691
Development. 2015 Apr 15;142(8):1418-30
pubmed: 25813539
Cell Cycle. 2016 Jul 2;15(13):1693-705
pubmed: 27267444
Nat Immunol. 2015 Jul;16(7):775-84
pubmed: 25985234
Neurogenetics. 2012 May;13(2):141-5
pubmed: 22434358
J Pediatr Hematol Oncol. 2002 Jun-Jul;24(5):337-42
pubmed: 12142780
Drugs. 2020 Apr;80(5):513-521
pubmed: 32166598
Cancer Cell. 2010 Oct 19;18(4):316-28
pubmed: 20951942
Cell Rep. 2017 Feb 28;18(9):2135-2147
pubmed: 28249160
J Natl Cancer Inst. 1999 Jun 2;91(11):974-5
pubmed: 10359553
Genes Cells. 2000 Jun;5(6):481-90
pubmed: 10886373
PLoS Genet. 2015 Dec 30;11(12):e1005748
pubmed: 26716708
Curr Biol. 2010 Sep 14;20(17):R754-63
pubmed: 20833320
Mol Cell Biol. 2013 Jan;33(2):360-70
pubmed: 23149935
Cancer Cell. 2019 Dec 9;36(6):597-612.e8
pubmed: 31708437
Neuropathology. 2018 Feb;38(1):47-53
pubmed: 28812319
J Mol Biol. 1997 Sep 12;272(1):1-8
pubmed: 9299332
Genetics. 1984 Dec;108(4):845-58
pubmed: 6392017
Neuropathol Appl Neurobiol. 2020 Feb;46(2):186-189
pubmed: 31077608
J Clin Oncol. 2004 Jul 15;22(14):2877-84
pubmed: 15254056
Mod Pathol. 2010 Jul;23(7):981-90
pubmed: 20305614
Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13015-20
pubmed: 11078522
Nat Genet. 1994 Aug;7(4):502-8
pubmed: 7951320
Acta Neuropathol. 2021 Aug;142(2):361-374
pubmed: 34003336
Cancer Discov. 2021 Oct;11(10):2620-2637
pubmed: 34078620
Nat Rev Genet. 2011 Jun;12(6):393-406
pubmed: 21502959
Cell Discov. 2020 Sep 22;6:66
pubmed: 33024572
Mod Pathol. 2008 Jun;21(6):647-52
pubmed: 18327209
Epigenetics Chromatin. 2020 Nov 3;13(1):48
pubmed: 33143733
Nat Genet. 2017 Feb;49(2):289-295
pubmed: 27941797
Cancer Cell. 2016 Mar 14;29(3):379-393
pubmed: 26923874
Cancer. 2006 Aug 1;107(3):606-12
pubmed: 16804932
Neuro Oncol. 2011 Dec;13(12):1296-307
pubmed: 21946044
Pediatr Dev Pathol. 2015 Jan-Feb;18(1):49-58
pubmed: 25494491
Brain Pathol. 2017 Jul;27(4):411-418
pubmed: 27380723
Cell. 2020 Oct 29;183(3):802-817.e24
pubmed: 33053319
Proc Natl Acad Sci U S A. 1997 Jul 8;94(14):7245-50
pubmed: 9207076
Genes Dev. 2003 May 1;17(9):1115-29
pubmed: 12695333
Acta Neuropathol. 2000 May;99(5):482-8
pubmed: 10805090
Oncogene. 2004 Apr 22;23(19):3462-73
pubmed: 14990991
Front Oncol. 2021 Feb 22;11:586288
pubmed: 33692948
Nat Rev Mol Cell Biol. 2006 Sep;7(9):678-89
pubmed: 16921404
Cancer Cell. 2016 Dec 12;30(6):891-908
pubmed: 27960086
Biology (Basel). 2021 Mar 27;10(4):
pubmed: 33801596
Mol Cancer Res. 2014 Nov;12(11):1574-85
pubmed: 25009291
Curr Oncol. 2020 Feb;27(1):e53-e56
pubmed: 32218668

Auteurs

Garrett W Cooper (GW)

Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA.
Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA 30322, USA.

Andrew L Hong (AL)

Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA.
Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA 30322, USA.
Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA.

Classifications MeSH